Free Trial

Owens & Minor (OMI) Competitors

$17.36
-0.31 (-1.75%)
(As of 06/7/2024 ET)

OMI vs. PDCO, MCK, COR, CAH, HSIC, DOCS, BBIO, OPCH, SMMT, and CRSP

Should you be buying Owens & Minor stock or one of its competitors? The main competitors of Owens & Minor include Patterson Companies (PDCO), McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Henry Schein (HSIC), Doximity (DOCS), BridgeBio Pharma (BBIO), Option Care Health (OPCH), Summit Therapeutics (SMMT), and CRISPR Therapeutics (CRSP). These companies are all part of the "medical" sector.

Owens & Minor vs.

Owens & Minor (NYSE:OMI) and Patterson Companies (NASDAQ:PDCO) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, community ranking, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.

In the previous week, Owens & Minor had 13 more articles in the media than Patterson Companies. MarketBeat recorded 17 mentions for Owens & Minor and 4 mentions for Patterson Companies. Owens & Minor's average media sentiment score of 0.65 beat Patterson Companies' score of 0.37 indicating that Owens & Minor is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Owens & Minor
9 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Patterson Companies
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Patterson Companies has a net margin of 2.95% compared to Owens & Minor's net margin of -0.37%. Patterson Companies' return on equity of 20.98% beat Owens & Minor's return on equity.

Company Net Margins Return on Equity Return on Assets
Owens & Minor-0.37% 12.97% 2.26%
Patterson Companies 2.95%20.98%7.70%

Owens & Minor currently has a consensus target price of $23.29, indicating a potential upside of 34.13%. Patterson Companies has a consensus target price of $31.67, indicating a potential upside of 33.17%. Given Owens & Minor's higher possible upside, equities research analysts clearly believe Owens & Minor is more favorable than Patterson Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owens & Minor
1 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Patterson Companies
0 Sell rating(s)
6 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.33

Patterson Companies received 111 more outperform votes than Owens & Minor when rated by MarketBeat users. Likewise, 52.39% of users gave Patterson Companies an outperform vote while only 48.54% of users gave Owens & Minor an outperform vote.

CompanyUnderperformOutperform
Owens & MinorOutperform Votes
250
48.54%
Underperform Votes
265
51.46%
Patterson CompaniesOutperform Votes
361
52.39%
Underperform Votes
328
47.61%

Patterson Companies has lower revenue, but higher earnings than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than Patterson Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owens & Minor$10.42B0.13-$41.30M-$0.51-34.04
Patterson Companies$6.57B0.32$207.56M$2.0311.71

Owens & Minor has a beta of 0.33, indicating that its stock price is 67% less volatile than the S&P 500. Comparatively, Patterson Companies has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500.

98.0% of Owens & Minor shares are owned by institutional investors. Comparatively, 85.4% of Patterson Companies shares are owned by institutional investors. 3.6% of Owens & Minor shares are owned by company insiders. Comparatively, 1.5% of Patterson Companies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Patterson Companies beats Owens & Minor on 12 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OMI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OMI vs. The Competition

MetricOwens & MinorMedical & hospital equipment IndustryMedical SectorNYSE Exchange
Market Cap$1.33B$7.56B$5.23B$17.71B
Dividend YieldN/A2.30%2.74%3.55%
P/E Ratio-34.0418.16122.6724.64
Price / Sales0.131.102,422.7914.45
Price / Cash3.4410.7235.2420.21
Price / Book1.442.184.974.99
Net Income-$41.30M$249.27M$110.48M$975.94M
7 Day Performance-0.40%-0.97%-1.08%-1.87%
1 Month Performance-4.19%-3.64%-0.68%-0.74%
1 Year Performance-18.65%-8.04%2.88%8.66%

Owens & Minor Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PDCO
Patterson Companies
4.1405 of 5 stars
$24.29
-0.9%
$31.67
+30.4%
-13.7%$2.18B$6.47B11.977,600
MCK
McKesson
4.3447 of 5 stars
$579.60
+1.0%
$571.47
-1.4%
+52.6%$75.34B$308.95B25.9051,000Analyst Downgrade
Insider Selling
COR
Cencora
4.0549 of 5 stars
$231.77
+0.5%
$233.90
+0.9%
+35.7%$46.23B$638.56M25.3646,000
CAH
Cardinal Health
3.8942 of 5 stars
$97.96
-0.4%
$107.57
+9.8%
+18.3%$23.86B$205.01B43.5448,000Positive News
HSIC
Henry Schein
3.6519 of 5 stars
$69.64
flat
$81.73
+17.4%
-9.0%$8.92B$12.34B23.5325,000
DOCS
Doximity
2.3689 of 5 stars
$28.49
+2.8%
$28.73
+0.8%
-9.7%$5.28B$475.42M39.57977
BBIO
BridgeBio Pharma
4.7308 of 5 stars
$28.00
+3.2%
$47.62
+70.1%
+63.3%$5.24B$9.30M-8.70550Analyst Forecast
Analyst Revision
News Coverage
OPCH
Option Care Health
4.6568 of 5 stars
$29.69
-2.1%
$40.00
+34.7%
-5.2%$5.16B$4.30B19.537,802Positive News
SMMT
Summit Therapeutics
1.6566 of 5 stars
$8.04
+10.0%
$13.50
+67.9%
+310.6%$5.13B$700,000.00-50.25105Gap Down
CRSP
CRISPR Therapeutics
2.1527 of 5 stars
$59.72
+2.5%
$73.46
+23.0%
-7.8%$5.07B$371.21M-21.96473Positive News

Related Companies and Tools

This page (NYSE:OMI) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners